National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
September 8, 2009 • Volume 6 / Number 17

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document

The information and links on this page are no longer being updated and are provided for reference purposes only.


Dr. William Dahut Named CCR Clinical Director

Dr. William Dahut Dr. William Dahut

Dr. William Dahut has been named the new clinical director of NCI’s Center for Cancer Research. Dr. Dahut will be the primary interface between NCI and the NIH Clinical Research Center for patient care and clinical operations. He will oversee areas critical to the Clinical Research Program, the quality of patient care, and the ability of principal investigators to develop and carry out clinical research protocols. These areas include data management, regulatory compliance, patient recruitment, credentialing, contract medical services, outpatient/inpatient census, training and continuing education, protocol development, information technology, patient travel and lodging, and space management.  

Dr. Dahut received his M.D. from Georgetown University and completed his clinical training in internal medicine at the National Naval Medical Center (NNMC) in Bethesda, MD, followed by further training in hematology and medical oncology at the NNMC and what was NCI’s Medicine Branch. Dr. Dahut worked as an attending physician in the NCI-Navy Medical Oncology Branch until 1995. He then joined the faculty of the Lombardi Cancer Center at Georgetown University before returning to NCI’s Medicine Branch in 1998 as head of the prostate cancer clinic. In 2002, Dr. Dahut became chief of the Genitourinary/Gynecological Clinical Research Section in what is now the Medical Oncology Branch. Dr. Dahut's primary research interest has been in the development of novel therapeutic strategies for the treatment of adenocarcinoma of the prostate.

NCI Tobacco Control Monograph Addresses Genetics of Nicotine Dependence

NCI Tobacco Control Monograph 20

NCI recently released Tobacco Control Monograph 20, Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence, which reviews the growing body of research findings in tobacco genetics to develop a scientific plan for incorporating genetic research into cross-disciplinary studies of nicotine dependence.

Tobacco-use behavior is dependent on complex genetic and environmental influences and interactions that are currently not well understood. Identifying different patterns of smoking behavior may help guide future research, tailor treatments for individual smokers more effectively, and enhance existing public health policy in tobacco prevention and control.

Monograph 20 presents new and innovative concepts and methodologies for the field of behavioral genetics and makes a strong case for continued and expanded research of genetic influences on tobacco use. A better understanding of the role of genetic susceptibility within the context of known environmental influences on tobacco use may advance the goals of the public health community to prevent and control tobacco use.

Past tobacco control monographs are available online.

CRCHD Hosted Professional Development and Diversity Training Conference

On August 5–6, NCI’s Center to Reduce Cancer Health Disparities (CRCHD) hosted a conference titled, The Path Forward: Training Fundamentals and Research Advancement. More than 80 grantees from CRCHD’s Continuing Umbrella of Research Experiences (CURE) program met in Rockville, MD, to share accomplishments, network, and learn professional development strategies that will drive career success. A number of the attendees received awards for their podium and poster presentation at the professional development workshop. 

The workshop “provides grantees with the opportunity to craft sound research career trajectories and enhance fundamentals like grantsmanship and publication,” said CURE Program Director Dr. LeeAnn Bailey.

< Previous Section